Patent Expiry for Semaglutide in India Opens Door for Cheaper Generic Versions of Weight-Loss Drug
english.ratopati.com
. 1 month ago
New Delhi. The patent for 'Semaglutide,' a drug considered highly effective in controlling obesity and diabetes in India, known as the pharmacy of the world, expired on Friday. With the patent held...
Comment
Liked by: